2023 Most Veteran Friendly in the Southeast Region for Pharmacology for a Bachelor’s
1
Ranked Colleges
23
Degrees Awarded
$22,000
Avg Cost*
When pursuing a degree in today’s world, veterans have many different options to choose from. College Factual has developed its “Most Veteran Friendly in the Southeast Region for Pharmacology for a Bachelor’s” ranking as one item you can use to help make this decision.
Pharmacology & Toxicology is the 233rd most popular major in the country with 1,042 degrees awarded in 2020-2021. In 2019-2020, pharmacology and toxicology graduates who were awarded their degree in 2017-2019, earned an average of $49,588 and had an average of $17,804 in loans still to pay off.
Across the Southeast region, there were 143 pharmacology and toxicology graduates with average earnings and debt of $24,009 and $15,779 respectively. At the bachelor’s degree level specifically, there were 23 pharmacology and toxicology graduates with average earnings and debt of $37,400 and $27,180 respectively.
The schools that top this list are recognized because they have great pharmacology and toxicology programs and a strong support system for veterans and active service members.
To come up with these rankings, we looked at factors such as veteran satisfaction, veteran affordability, and overall quality of the pharmacology and toxicology program at the school. Check out our ranking methodology for more information.
One Size Does Not Fit All
The pharmacology school you choose to invest your time and money in matters. To help you make the decision that is right for you, we’ve developed a number of major-specific rankings, including this list of “Most Veteran Friendly in the Southeast Region for Pharmacology for a Bachelor’s”.
One of our other unique offerings is College Combat. This tool lets you build your own customized comparisons utilizing the factors that are most important to you. Test it out by comparing your favorite schools against others you are considering, or bookmark the tool so you can experiment with it later.